Product take-back legislation forces manufacturers to bear the costs of collection and disposal of products that have reached the end of their useful lives. In order to reduce these costs, manufacturers can consider reuse, remanufacturing and/or recycling of components as an alternative to disposal. The implementation of such alternatives usually requires an appropriate reverse supply chain man...

In this research, we have investigated the interaction between product platform development and supply chain configuration in a global environment. A comprehensive decision support model has been developed to simultaneously determine product strategy and supply chain configuration. By Products we refer to the bundle of module option alternatives offered to market segments, and product platform ...

Agility is the fundamental characteristic of a supply chain needed for survival in turbulent markets, where environmental forces create additional uncertainty resulting in higher risk in the supply chain management. In addition, agility helps providing the right product, at the right time to the consumer. The main goal of this research is therefore to promote supplier selection in pharmaceutica...

Agility is the fundamental characteristic of a supply chain needed for survival in turbulent markets, where environmental forces create additional uncertainty resulting in higher risk in the supply chain management. In addition, agility helps providing the right product, at the right time to the consumer. The main goal of this research is therefore to promote supplier selection in pharmaceutica...

Key challenge for mastering high uncertainty of both demand and supply is to attune products and business processes in the entire supply chain continuously to customer requirements. Product configurators have proven to be powerful tools for managing demand uncertainty. This paper assesses how configurators can be used for combined product and process configuration in order to support mastering ...

the supply chain represents the critical link between the development of new product and the market in pharmaceutical industry. over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. in addition, powerful regulatory and market forces have provided new incentives for pharmaceutical firms to basically rethink the wa...

We address how to configure the supply chain for a new product whose design has already been decided. The central question is to determine what suppliers, parts, processes and transportation modes to select at each stage in the supply chain. There might be multiple options to supply a raw material, to manufacture or assemble the product, and to transport the product to the customer. Each of the...